Cointime

Symic Biomedical

company

About

SYMIC Biomedical operates in the healthcare industry focusing on biotechnology business.

  • 1 - 10

Highlights

Total Funding Amount
$1.76M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Grant
Last Funding Money Raised
$1.50M
Industries
Biotechnology,Business Intelligence,Health Care
Founded date
Jan 1, 2012
Number Of Employee
1 - 10
Operating Status
Active

Symic Biomedical is a developer of matrix regulator therapeutics designed to affect matrix degradation and structure. The company's therapeutics bind to targets in the matrix, damaged in response to injury or because of disease, to inhibit pathological inflammatory responses, enabling clinicians to investigate applications in the areas of fibrosis, oncology and diseases of the central nervous system.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.76M
Symic Biomedical has raised a total of $1.76M in funding over 2 rounds. Their latest funding was raised on Aug 27, 2015 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 27, 2015 Grant $1.50M 1 — — Detail
Jun 3, 2014 Grant $269.41K 1 National Science Foundation — Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Symic Biomedical is funded by 2 investors. National Science Foundation and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant
National Institutes of Health — Grant
Cointime
เนื้อหา
บริษัท